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An association between vitamin D deficiency and early dental implant failure is not properly verified, but its role in
osteoimmunology is discussed. This article illustrates two case reports with vitamin D deficiency and early implant
failure. Prior to implant placement, the first patient received crestal bone grafting with autologous material. Both
patients received dental implants from different manufacturers in the molar region of the mandible. In the case of
bone grafting in the first patient, all implants were placed in a two-stage procedure. All implants had to be
removed within 15 days after implant placement. Vitamin D serum levels were measured: Both patients showed a
vitamin D deficiency (serum vitamin D level <20 μg/l). After vitamin D supplementation, implant placement was
successful in both patients. Prospective, randomized clinical trials must follow to affirm the relationship between
vitamin D deficiency, osteoimmunology, and early implant failure.
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Long-term stable osseointegrated implants are the pri-
mary goal in dental implantology. Although dental im-
plants have proven clinical reliable in the long term, the
failure of implants at a very early stage of osseointegra-
tion has been described [1, 2]. The pursuit to identify
the mechanisms leading to early implant failure is on-
going to date and include the following: tobacco usage,
diabetes, wear particle release and foreign body reaction,
local bone necrosis due to heat generation during bone
preparation or implant placement [2–9]. Systematic re-
views demonstrated that an antibiotic regimen before
dental implant placement subtly reduces the early im-
plant infection and consequently implant failure [10, 11].
In orthopedics, the risk to develop a periprosthetic joint
infection has been associated with a low vitamin D level
[12]. A relationship between bone metabolism, vitamin
D, and early implant failure in human has not been
proven to date. Vitamin D induces bone formation* Correspondence: tobias.fretwurst@uniklinik-freiburg.de
1Department of Oral- and Craniomaxillofacial Surgery, Center for Dental
Medicine, University Medical Center Freiburg, Hugstetter Straße 55, Freiburg
D-79106, Germany
2Department of Periodontics and Oral Medicine, University of Michigan
School of Dentistry, Ann Arbor, USA
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article
International License (http://creativecommons.o
reproduction in any medium, provided you giv
the Creative Commons license, and indicate ifaround implants in rodents [13–17]. Besides the classical
function, findings of the last decades indicate vitamin D as
an important immune regulator targeting both, the innate
and adaptive immune response, since all cells of the im-
mune system express vitamin d receptor (VDR) [18–20].
The definition of vitamin D serum level is discussed in
the literature [21–25]. Currently, vitamin D insufficiency
is defined as serum level ranges between 21 and 29 μg/l,
a serum level below <20 μg/l as vitamin D deficiency
(severe deficiency <10 μg/l) [22, 25, 26]. The prevalence
of vitamin D deficiency in Europe varies widely with
ranges between 2 to 30% in adults and up to 80% in eld-
erly patients [27]. Malnutrition, insufficient sun expos-
ure, premature and dysmature birth, pigmented skin,
obesity and advanced age are known as factors for a vita-
min D deficiency [28].
A current review article demands the investigation of
vitamin D deficiency in the context of dental implant
failures [16]. To address this demand, the present case
reports raised the question if vitamin D deficiency influ-
ences implant survival in the early stages of healing. This
article illustrates two apparently healthy patients with
vitamin D deficiency and early implant failure and dem-
onstrates that implant placement was successful after
vitamin D supplementation.is distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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Patients and surgical procedure
Patients treated consecutively in one center (Department
of Oral- and Craniomaxillofacial Surgery, University
Medical Center Freiburg). None of the patients showed
systemic disease. Both patients did not take regular
medication and were negative for alcohol, nicotine, and
drug use. Bothe male patients (48 and 51 years of age)
were not immunosuppressed, irradiated or received
chemotherapy. Written informed consent was obtained
from the patient for publication of this case report and
accompanying images. An ethic committee approval and
consent was not necessary. This case report was per-
formed in accordance with the Helsinki Declaration of
1964, as revised in 2013. Both patients lost their teeth
several years before implant placement. The reason for
extraction was not evaluable since both patients were re-
ferred for grafting and implant placement.
Surgery for bone augmentation and implant placement
was performed under local anesthesia with Ultracain
forte (Sanofi Aventis, Frankfurt, Germany) following a
standard operation protocol. In the augmentation pro-
cedure, a crestal incision in the attached gingiva of the
edentulous alveolar crest with one vertical releasing inci-
sion was used, after mobilization of the mucoperiostealFig. 1 a Patient 1. Post grafting orthopantomogram. The bone block was s
demonstrates veritable inserted Straumann bone level implants after the fir
osteolysis is not visible. c Patient 1. Postoperative orthopantomogram (1 da
Straumann tissue level implants 6 months later. A peri-implant osteolysis is
implant placement (Conelog ScrewLine implant)flap an autologous retromolar bone block was fixed on the
occlusal part of the alveolar ridge. The bone block was se-
cured with a microscrew (Modus 1.5, Medartis, Umkirch,
Germany) and covered with a resorbable membrane
(BioGide, Geistlich AG, Switzerland) as described previ-
ously [29]. The passively mobilized mucosa was closed
with a running suture and secured with interrupted
sutures (5-0 Monocryl, Ethicon, Norderstedt, Germany).
All implants were inserted with the same recom-
mended torque of <35 Ncm. A standard oral antibiotic
regimen was not applied after implant placement.
Both patients were clinically evaluated after one, ten
and thirty days. All bone grafting procedures and im-
plant placements were performed by two experienced
surgeons (KN and SG). Oral radiographic examinations
(orthopantomograms) were performed before and one
day after the surgical procedure.
Patient
The medical history of this 48-year-old male patient showed
a high blood pressure; otherwise, the patient was healthy. A
successfully completed periodontal therapy was done before
implant therapy. The patient demonstrated stable marginal
bone levels. Autologous retromolar bone grafting using local
anesthesia was performed in the left mandible (see Fig. 1a).ecured with a single microscrew. b Patient 1. The radiograph
st implant placement (1 day after implant placement). A peri-implant
y after implant placement) after second implant placement of
not visible. d Patient 1. Postoperative orthopantomogram after third
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with amoxicillin 750 mg for 3 days. Three months after
grafting two implants (Straumann, bone level) were placed
in regions 36 and 37 (implant characteristic, see Table 1).
During implant placement, cortical bone profiling was per-
formed as recommended by the manufacturer guidelines.
The bone graft appeared fully revascularized and incorpo-
rated. One day postoperatively the patient reported to have
pain. The radiograph performed on that day demonstrated
veritable inserted Straumann bone level implants. A peri-
implant osteolysis was not visible (Fig. 1b). After 3 days of
continuous severe pain, both implants were removed. At
the time point of explantation, the local soft tissue showed
no signs of inflammation. During surgical removal of the
implants, an extensive osteolysis surrounding the implants
was found and a thorough debridement of the area with a
complete wound closure was performed. A second implant
surgery was scheduled after 6 months with placement of
two implants (Straumann, tissue level) in regions 36 and 37
(Fig. 1c). At reentry, the mandible appeared well vascular-
ized; no granulation tissue was detectable. The drilling
protocol was performed as recommended by the manufac-
turer including a cortical bone profiling before implant
placement. Again after 3 days, both implants had to be re-
moved because of continuous severe pain in the absence of
any sign of soft tissue inflammation, swelling, or abscess
formation.
At this time point, a screening of the relevant parame-
ters for bone metabolism was performed and a vitamin
D deficiency (vitamin D serum level 11 μg/l) was diag-
nosed. After vitamin D supplementation and a healing
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Successfulplanned and one implant (Conelog ScrewLine) was
inserted in region 36 (see Table 1 and Fig. 1d). During
implant placement, the former explantation site ap-
peared clinically fully re-ossified. The patient received an
intraoperative intravenous single-dose antibiotic therapy
with Isocillin 1.2 mega. At this time point, the patient
demonstrated a vitamin D level of 46 μg/l. Second-stage
surgery was successfully performed and the prosthetic
restoration initiated. For all implants, a primary stability
had been achieved.
Patient
In this 51-year-old male patient, no grafting procedure
was performed as vertical and horizontal alveolar ridge
dimension was adequate for implant placement. The im-
plant placement in regions 36 and 37 was performed as
guided surgery (Fig. 2a, Table 1). The implant placement
was uneventful and the bone appeared clinically healthy.
A cortical bone profiling was performed during implant
placement. One day postoperatively, the patient reported
of a discomfort in the area of the operation but not se-
vere pain. On day 7 postoperatively during a routine
examination, the patient complained of continuous in-
creasing severe pain since the operation. A medicinal
pain therapy (ibuprofen 600 mg) was ineffective so that
an explantation of both implants was performed at day
15. The serum vitamin D level showed an incipient defi-
ciency (serum vitamin D level 20 μg/l). After vitamin D
supplementation, a second implant placement in region
37 was performed successfully 4 months later. In region
36, a bony defect filled with granulation tissue was dis-
covered and a debridement performed. Implant place-
ment in region 36 was performed 8 weeks after the
debridement (6 months after the first implant place-
ment) (see Fig. 2b). The follow-up of both implants was
uneventful and the prosthetic restoration performed. For
all implants, a primary stability has been achieved. In
both patients, appropriate torque was achieved using the
system specific torque meter. After detailed vitamin D
anamnesis malnutrition and insufficient sun exposure
could be excluded as cause for vitamin D deficiency in
both patients.
Discussion
This article demonstrated that implant placement was
successful after vitamin D supplementation in patients
with vitamin D deficiency and early failed implants.
None of the patients showed systemic disease or did take
regular medication, alcohol, nicotine, or drugs. The pa-
tients were not immunosuppressed, irradiated, or re-
ceived chemotherapy. All implants were inserted with
the same recommended torque of <35 Ncm. Bone over-
heat or compression due to implant preparation/place-
ment or contamination of implants surface during the
Fig. 2 a Patient 2. Postoperative orthopantomogram one day after implant placement. b Patient 2. Postoperative orthopantomogram after
second Implant placement
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gation and the surgical protocol. In the end, only com-
mon obvious deficit of both patients was vitamin D
deficiency. The blood analysis was otherwise unsuspi-
cious. However, in the first patient, implants were placed
3 months after vertical autogenous bone augmentation
with no systemic antibiotic treatment while antibiotics
were given during the third successful attempt several
months after guided bone regeneration. Missing antibiotic
treatment and the grafting procedures have to be consid-
ered as conceivable factors for the early implant failure in
the present patients nonetheless [10, 11]. To date, a vita-
min D screening before implant placement has not be-
come standard in our clinic; but in patients with early
implant failure, a vitamin D screening is initiated.
Local and systemic factors can affect the survival rate of
dental implants [30–33]. The causes of early implant fail-
ure are not fully clarified and an association between vita-
min D and dental implant osseointegration has not been
investigated properly [8, 13–16]. Some recent animal stud-
ies in rodents demonstrated a relationship between vita-
min D supplementation and an increased bone to implant
contact/volume after implant placement [14, 34, 35].
Mengatto et al. demonstrated an impaired osseointegra-
tion in vitamin D-deficient rats [36]. Other authors cannot
confirm an effect of vitamin D supplementation on bone
formation around titanium implants in diabetic rats [37].
A combination of local or systemic calcium supplementa-
tion and vitamin D seems to influence bone regeneration
in extraction sockets of the dog as it demonstrates signifi-
cantly higher bone formation and bone density and signifi-
cantly less vertical ridge reduction in contrast to sockets
without supplementation [38, 39]. However, a present hu-
man study cannot confirm an effect due to vitamin D sup-
plementation on bone formation or graft resorption after
maxillary sinus augmentation [40]. Satue et al. found a
positive influence of 7-dehydrocholesterol (7-DHC), the
precursor of vitamin D, coated implants on osteoblastdifferentiation in vitro [41]. But whether vitamin D-coated
dental implants have an effect of osseointegration in vivo
is still unclarified [42].
In dental implantology, vitamin D has been investi-
gated almost exclusively as influencing factor of the
bone to implant contact and implant stability [17]. Vita-
min D demonstrates several effects on bone metabolism:
it upregulates the gene expression of osteocalcin, osteo-
pontin, calbindin, and 24-hydroxylase, increases extra-
cellular matrix protein formation by osteoblasts, and
stimulates osteoclast activity [15, 43]. But beyond modu-
lation of bone formation, vitamin D has an impact on
the innate and adaptive immune response in the field of
osteoimmunology and could therefore influence early
implant healing [19, 44–49].
Bone necrosis during implant bed preparation or
placement is considered as a reason for early implant
failures [7, 8]. An additional vitamin D deficiency might
disrupt the sensitive balance between the immune sys-
tem and bone metabolism during implant healing due to
direct or indirect alteration of osteoclast function. For
instance, the removal of bone debris through osteoclasts
could be hampered since vitamin D controls osteoclast
precursor monocyte migration [50]. On the other hand,
in vitro studies demonstrated that vitamin D inhibits
dendritic cell maturation and function as well as T cell
proliferation and influences B cell responses, inhibiting
proliferation and plasma cell differentiation [51–54]. An
altered cytokine release by immune cells caused by a low
vitamin D level could lead to a dysregulation of osteo-
clast activation and differentiation via associated immu-
noreceptors in osteoclasts [55].
Nevertheless, the vitamin D deficiency prevalence in
the European population indicates that a vitamin D defi-
ciency is probably not a sole causative factor for early
implant failure; otherwise, the early implant failure rate
would be significantly higher. However, a synergistic ef-
fect with other factors is conceivable. Some authors
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wound healing phenomenon but rather complex foreign
body reaction with activation of the immune system
[56]. Titanium and metal particle release is discussed
as cause for implant failure as well as implant dentistry
[5, 6, 9, 56, 57]. It is assumed that metal particles influence
the macrophage or lymphocyte pathways and provoke a
release of pro-inflammatory cytokines, leading to an in-
creased osteoclastogenesis and decreased osteoblastogene-
sis and consequently to peri-implant bone loss [58]. This
osteolytic effect could be enhanced by vitamin D defi-
ciency, since Maier et al. demonstrated in an epidemio-
logical study that vitamin D deficiency is associated with a
higher risk to develop aseptic loosening around joint re-
placements caused by wear particles [59]. Vitamin D could
also be essential for the antibacterial response, as
monocyte-macrophage reaction is influenced by vitamin
D [60]. Xu et al. demonstrated that vitamin D can inhibit
Porphyromonas gingivalis-induced proinflammatory cyto-
kine expression and improve the expression of anti-
inflammatory cytokines in macrophages [53].
Interestingly, in the present investigation, the osseoin-
tegration of dental implants seems to be more influ-
enced by the vitamin D level than the autologous graft
incorporation as the graft incorporation was not com-
promised. The eventually minor effect of vitamin D on
the incorporation of bone grafts appears to be addressed
by the results of a current randomized, double-blind,
and placebo-controlled clinical investigation with a high-
dose vitamin D3 supplementation combined with cal-
cium. The results could not demonstrate a statistically
significant difference in the amount of bone formation
or graft resorption after maxillary sinus augmentation
compared to a placebo medication [40].Conclusions
To overcome the shortcomings of this case reports, pro-
spective, multicenter, and controlled studies must follow
to affirm a potential relationship between vitamin D
deficiency, osteoimmunology, and the early failure of
dental implants. Currently, a general recommendation
for a standardized vitamin D screening in dental implan-
tology cannot be stated due to lack of evidence.
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